Which stocks could surge or slide? Anil Singhvi shares his market calls; check price targets
Published on 06/11/2025 11:20 AM
Market expert and Zee Business Managing Editor Anil Singhvi has lined up a mixed set of trading ideas for Thursday. His latest calls, shared on Zee Business, cover a blend of large-cap names from healthcare, pharma, FMCG, metals and logistics sectors.
Singhvi’s bullish stance was evident in picks such as Fortis Healthcare, Metropolis Healthcare, Paytm, Sun Pharma, Britannia Industries, and Astral. Each of these, he said, reflects solid fundamentals and strong quarterly trends. On the other hand, he advised caution in Hindalco and Syngene, which came under pressure after weaker operational performance.
According to Singhvi, Fortis Healthcare could stay in focus following its inclusion in the MSCI Global Index, which he termed a significant positive for the stock. The near-term targets are Rs 1,035 and Rs 1,055, with a stop-loss at Rs 998.
He also recommended Metropolis Healthcare, calling its results “exceptionally strong on all counts.” The stock is a buy in the cash segment with targets of Rs 2,100, Rs 2,140 and Rs 2,175, and a stop-loss at Rs 1,995.
In Sun Pharma, Singhvi expects further upside driven by steady Indian operations and consistent growth in its US speciality business. The stock has targets between Rs 1,715 and Rs 1,740, with a stop-loss placed at Rs 1,685.
Among FMCG names, Singhvi recommended Britannia Industries, noting improved growth visibility and potential valuation re-rating. The stock, he added, still trades about 15 per cent below Nestlé India, making it attractively priced. Targets are set at Rs 6,040, Rs 6,110, and Rs 6,165, while the stop-loss stands at Rs 5,885.
He maintained a bullish outlook on Paytm as well, pointing to a sharp improvement in results and inclusion in the MSCI Global Index. Singhvi cited strong performance across business segments, with targets at Rs 1,290, Rs 1,310, Rs 1,325 and Rs 1,350, and a stop-loss at Rs 1,260.
In contrast, Hindalco Industries was placed in the sell category amid weakness in global commodity markets and subdued earnings from its subsidiary, Novelis. The stock’s targets are Rs 823 and Rs 810, with a stop-loss at Rs 846.
Syngene International, too, was added to the sell list after a disappointing quarter. Singhvi expects the stock to drift lower toward Rs 637 and Rs 632, with a stop-loss at Rs 662.
Among other stocks, Delhivery, Kaynes Technology, Grasim, InterGlobe Aviation, and Blue Star saw mixed views. Singhvi remains optimistic on Blue Star following strong numbers, while cautioning that Kaynes Tech looks expensive after a modest earnings cut.
Senior Sub-editor at Zee Business English
shweta.shukla@India.com
Shweta Birendra Shukla is a journalist covering the stock market and corporate aff